In addition, IgA class-switched IL10+PD-L1+ plasma cells can attenuate CTL activation in a TGFB-dependent manner, thereby hindering anti-tumour activity (Shalapour et al. 2015). This evidence concerns the gene TGFB1 and neoplasm.